Seunguk Oh

430 citations
9 papers · 339 indexed · h-index 9
Topics
Toxin Mechanisms and Immunotoxins (4 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)CAR-T cell therapy research (2 papers)

In The Last Decade

Seunguk Oh

9 papers receiving 333 citations

Peers

Seunguk Oh
Comparison fields: 5 of 72
  • Immunology 133
  • Oncology 127
  • Molecular Biology 86
  • Radiology, Nuclear Medicine and Imaging 75
  • Neurology 40
Replace Haruki Hasegawa with:
Haruki Hasegawa United States
Debarshi Banerjee United States
Colleen M. Britain United States
Vanita D. Sood United States
Christopher M. Murawsky United States
Douglas Sheridan United States
Mia Rushe United States
Nadia Martinez-Martín United States
A Wolff France
Eric Fourmaux France
Seunguk Oh relative to Haruki Hasegawa United States Haruki Hasegawa's profile →
Citations per field
00.5×2.7×
Haruki Hasegawa · 1×
Citations per year

Countries citing papers authored by Seunguk Oh

Since Specialization
Citations

This map shows the geographic impact of Seunguk Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seunguk Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seunguk Oh more than expected).

Fields of papers citing papers by Seunguk Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seunguk Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seunguk Oh. The network helps show where Seunguk Oh may publish in the future.

Co-authorship network of co-authors of Seunguk Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Seunguk Oh. A scholar is included among the top collaborators of Seunguk Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seunguk Oh. Seunguk Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 82
2 26
3 33
4 10
5 25
6 33
7 27
8 59
9 44

About Seunguk Oh

Seunguk Oh is a scholar working on Computer Graphics and Computer-Aided Design, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 9 papers that have together received 339 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Acoustics and Ultrasonics (6 citations), Immunology (133 citations) and Oncology (127 citations). Seunguk Oh has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Daniel A. Vallera, John R. Ohlfest, Bin Zhang, Valarie McCullar, Louis M. Weiner, Jeffrey S. Miller, Sang‐Jun Lee, Michelle Gleason, Jung‐Han Kim and Bong-Sik Yun. Their work appears in journals such as Clinical Cancer Research, Journal of neurosurgery and The Journal of Antibiotics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026